Author
Technical Director BDR PHARMACEUTICALS
Diabetes, particularly type 2, has been linked to an increased risk of developing dementia and Alzheimer’s disease. Research indicates that individuals with diabetes are 50-100 per cent more likely to develop cognitive impairments compared to non-diabetic individuals
Read More
